Shoya Iwanami

Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment

Hirofumi Ohashi, Koichi Watashi, Wakana Saso et al. · iScience · 2021 · 180 citations · Full text

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2

Kwang Su Kim, Keisuke Ejima, Shoya Iwanami et al. · PLoS Biology · 2021 · 160 citations · Full text

Multidrug treatment with nelfinavir and cepharanthine against COVID-19

Hirofumi Ohashi, Koichi Watashi, Wakana Saso et al. · 2020 · 83 citations

Immunology, Immunotherapeutics, Antiviral Drug +17

Factors Associated with COVID-19 Vaccine Booster Hesitancy: A Retrospective Cohort Study, Fukushima Vaccination Community Survey

Makoto Yoshida, Yurie Kobashi, Takeshi Kawamura et al. · Vaccines · 2022 · 72 citations · Full text

Immunodeficiencies, Covid-19 Epidemiology, Vaccine Hesitancy +19

Estimation of the incubation period of COVID-19 using viral load data

Keisuke Ejima, Kwang Su Kim, Christina Ludema et al. · Epidemics · 2021 · 71 citations · Full text

Viral Load Data, Incubation Period, Viral Load +12